RxDoctor Payments Data

Sean Hurley, MD

Internal Medicine · Spokane, WANPI 1477655579

Payments from drug & device makers

$6,043in general payments, 2019–2025

Across 32 payments — averaging $188.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$5K
  • Novo Nordisk$172
  • Johnson & Johnson$92
  • Takeda Pharmaceuticals U.S.A., Inc.$51
  • Pfizer$49
  • Otsuka America Pharmaceutical, Inc.$46
  • plus $187 from 7 others

What the payments were for

  • Food & beverage$597100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,043 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.

See all internal medicine providers in Washington

Medicare billing

Part B allowed, 2024
$98,272
Medicare patients
225
Services billed
1,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban98$102,062
JardianceEmpagliflozin42$66,311
JanuviaSitagliptin Phosphate67$60,868
OzempicSemaglutide46$44,492
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen137$4,039
Atorvastatin Calcium255$3,509
Celecoxib45$2,906
SymbicortBudesonide/Formoterol Fumarate12$2,711
Levothyroxine Sodium240$2,383
Gabapentin88$2,367
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,357
Omeprazole145$2,070
Losartan Potassium199$1,817
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,674
Lisinopril187$1,369

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$49$102,06298 claims
Boehringer IngelheimJardiance$44$66,31142 claims
Novo NordiskOzempic$172$44,49246 claims
AstraZenecaSymbicort$5,446$2,71112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,038 internal medicine providers in Washington.

Other internal medicine in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →